Abstract:
The invention relates to compositions and methods for analyzing and treating a disease, disorder, or condition associated with an XMRV infection.
Abstract:
The invention relates to compositions and methods for analyzing and treating a disease, disorder, or condition associated with an XMRV infection.
Abstract:
The present invention provides a method for the manufacture of a fermented product, which is capable of being mixed with at least sweetener and water to form kvas beverage comprising the steps of either: a) blending kvas wort with sweetener, b) fermenting product of a) with yeast to provide an ethanol content of 2.5%-5% v/v c) separating yeast from product of b), d) distilling fermented separated wort product of c) to produce a concentrated wort with a solids content of at least 65% measured as refractometric Brix and e) heat treating wort concentrate of d); or ai) blending kvas wort concentrate with sweetener and water to produce wort with 15-40%, e.g. 15-34%, solids content, bi) fermenting product of step ai) with yeast to obtain 4-13% v/v ethanol and ci) separating yeast from product of bi). The invention further concerns a method for producing kvas beverage or a syrup which can be diluted to form kvas beverage, together with a concentrated fermented kvas wort, a fermentate, a syrup and kvas beverage obtainable by carrying out the methods of the invention.
Abstract:
The invention relates to compositions and methods for analyzing and treating a disease, disorder, or condition associated with an XMRV infection.